Here are six things to know:
1. The company reported net sales of $3.3 billion in the second quarter, a 10.3 percent increase year-over-year.
2. Within its orthopedic segment, Stryker experienced an 7.6 percent increase year-over-year, reaching $1.2B in sales. The company’s medsurg segment also saw a 8.9 percent increase year-over-year.
3. Stryker’s neurotechnology and spine segment reported $600M in sales, a 19.4 percent increase year-over-year.
4. Stryker’s earnings per share increased 15.5 percent to $1.19, compared to the same quarter last year.
5. The company reported net earnings of $452 million, a 15.6 percent increase year-over-year.
6. Stryker expects its adjusted net earnings per diluted share to sit between $7.22 and $7.27 at the end of the year.
More articles on devices and implants:
5 things to know about Aesculap Implant Systems
5 things to expect from Stryker’s Q2 results
Sen. Todd Young calls on President Trump, Congress to end medical device tax — 6 insights
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
